Our concept: a group of passionate chemists gathers for an hour-long experience - a journey into the future of chemistry and discovery.
In this SpiroWebinars Autumn Series (Pushing Boundaries), we will be covering a topic that keeps us all awake at night: how to construct better molecules with better properties?Get to know us
Get to know us.
Prof. Daniele Leonori
PhD, Professor at the University of Manchester
Dr. Quentin Lefebvre, PhD
PhD, Research Chemist at SpiroChem and expert in photoredox catalysis, among other things
PhD Benjamin Perry
PhD, Senior Discovery Manager at Drugs for Neglected Diseases initiative (DNDi) and Scientific Advisor of SpiroChem
Prof. Dr. Richmond Sarpong University of California, Berkeley
Professor at the University of California, Berkeley
At what time?
In this webinar, Prof. Daniele Leonori will give you in-depth knowledge on the topic of Photoinduced Assembly of C-N and C-C bonds
In this webinar, Dr. Quentin Lefebvre, PhD, Research Scientist at SpiroChem, will give you in-depth knowledge on the topic of new methodologies and enabling technologies to decorrelate structural complexity from synthetic accessibility
In this webinar, PhD Benjamin Perry will give you an in-depth scientific tour through the world of Design of highly 3D libraries and case studies
In this webinar, Prof. Dr. Richmong Sarpong will take you through Break-it-to-Make-it Strategies for Chemical Synthesis Inspired by Complex Natural Products.
Pushing boundaries: Photoinduced Assembly of C-N and C-C bonds
Pushing boundaries: New methodologies and enabling technologies to decorrelate structural complexity from synthetic accessibility
Pushing boundaries: Design of highly 3D libraries and case studies
Pushing boundaries: Break-it-to-Make-it Strategies for Chemical Synthesis Inspired by Complex Natural Products
Ben Perry is currently Senior Discovery Manager at Drugs for Neglected Diseases initiative (DNDi), where he is responsible for Discovery Open Innovation. At DNDi he has led the NTD Drug Discovery Booster since inception, and has been involved with the conception and implementation of several other initiatives focused on leishmaniasis and Chagas disease drug discovery at DNDi, including the Open Synthesis Network and the MycetOS projects. Prior to joining DNDi, Ben spent 15 years in various medicinal chemistry roles at Celltech (UK), UCB (UK; Belgium), Addex Therapeutics (Switzerland) and Genkyotex (Switzerland).
He has worked extensively in early-stage drug discovery across a variety of disease indications including oncology, autoimmune disorders, neurodegeneration and psychiatry.
His areas of research interest include the use of chemoinformatic and computational tools within medicinal chemistry, alternative research mechanisms, and the use of new technologies and research collaborations to further the drug discovery process. Ben holds a PhD in organic chemistry from Imperial College London and a MBA from IE Business School, Madrid.
The webinar you do not want to miss. Fulfill the form and get access to the SpiroWebinars. Right now.
Let us inspire you. Subscribe to our newsletter to keep updated on new webinars, products, solutions & more.